Skip to main content
Have a personal or library account? Click to login
Evaluation of Resveratrol and Piceatannol Cytotoxicity in Macrophages, T Cells, and Skin Cells Cover

Evaluation of Resveratrol and Piceatannol Cytotoxicity in Macrophages, T Cells, and Skin Cells

Open Access
|Oct 2007

References

  1. Delmas D, Lancon A, Colin D, Jannin B, Latruffe N. Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer.2006;7:423-42.
  2. Ibern-Gomez M, Roig-Perez S, Lamuela-Raventos RM, Torre-Boronat MC. Resveratrol and piceid levels in natural and blended peanut butters.2000;48:6352-4.
  3. Burns J, Yokota T, Ashihara H, Lean ME, Crozier A. Plant foods and herbal sources of resveratrol.2002;50:3337-40.
  4. Sobolev VS, Cole RJ. Trans-resveratrol content in commercial peanuts and peanut products.1999;47:1435-9.
  5. Soleas GJ, Diamandis EP, Goldberg DM. Resveratrol: a molecule whose time has come? And gone?1997;30:91-113.
  6. Basly JP, Marre-Fournier F, Le Bail JC, Habrioux G, Chulia AJ. Estrogenic/antiestrogenic and scavenging properties of (E)- and (Z)-resveratrol.2000;66:769-77.
  7. Gehm BD, McAndrews JM, Chien PY, Jameson JL. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor.1997;94:14138-43.
  8. el Mowafy AM, Abou-Zeid LA, Edafiogho I. Recognition of resveratrol by the human estrogen receptor-alpha: a molecular modeling approach to understand its biological actions.2002;11:86-92.
  9. Jeandet P, Douillet-Breuil AC, Bessis R, Debord S, Sbaghi M, Adrian M. Phytoalexins from the Vitaceae: biosynthesis, phytoalexin gene expression in transgenic plants, antifungal activity, and metabolism.2002;50:2731-41.
  10. Watts KT, Lee PC, Schmidt-Dannert C. Biosynthesis of plant-specific stilbene polyketides in metabolically engineered Escherichia coli.2006;6:22.
  11. Pervaiz S. Resveratrol: from grapevines to mammalian biology.2003;17:1975-85.
  12. Ulrich S, Wolter F, Stein JM. Molecular mechanisms of the chemopreventive effects of resveratrol and its analogs in carcinogenesis.2005;49:452-61.
  13. Bhat KPL, Kosmeder JW, Pezzuto JM. Biological effects of resveratrol.2001;3:1041-64.
  14. Kris-Etherton PM, Hecker KD, Bonanome A, Coval SM, Binkoski AE, Hilpert KF, Griel AE, Etherton TD. Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer.2002;113(Suppl 9B):71S-88S.
  15. Crowell JA, Korytko PJ, Morrissey RL, Booth TD, Levine BS. Resveratrol-associated renal toxicity.2004;82:614-9.
  16. de la Lastra CA, Villegas I. Resveratrol as an antiinflammatory and anti-aging agent: mechanisms and clinical implications.2005;49:405-30.
  17. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes.1997;275:218-20.
  18. Falchetti R, Fuggetta MP, Lanzilli G, Tricarico M, Ravagnan G. Effects of resveratrol on human immune cell function.2001;70:81-96.
  19. Ragione FD, Cucciolla V, Borriello A, Pietra VD, Racioppi L, Soldati G, Manna C, Galletti P, Zappia V. Resveratrol arrests the cell division cycle at S/G2 phase transition.1998;250:53-8.
  20. Bernhard D, Tinhofer I, Tonko M, Hubl H, Ausserlechner MJ, Greil R, Kofler R, Csordas A. Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cells.2000;7:834-42.
  21. Tsan MF, White JE, Maheshwari JG, Chikkappa G. Anti-leukemia effect of resveratrol.2002;43:983-7.
  22. Zunino SJ, Storms DH. Resveratrol-induced apoptosis is enhanced in acute lymphoblastic leukemia cells by modulation of the mitochondrial permeability transition pore.2006;240:123-34.
  23. Wu SL, Yu L, Pan CE, Jiao XY, Lv Y, Fu J, Meng KW. Apoptosis of lymphocytes in allograft in a rat liver transplantation model induced by resveratrol.2006;54:19-23.
  24. Jang DS, Kang BS, Ryu SY, Chang IM, Min KR, Kim Y. Inhibitory effects of resveratrol analogs on unopsonized zymosan-induced oxygen radical production.1999;57:705-12.
  25. Djoko B, Chiou RY, Shee JJ, Liu YW. Characterization of immunological activities of peanut stillbenoids, arachidin-1, piceatannol, and resveratrol on lipopolysaccharide-induced inflammation of RAW 264.7 macrophages.2007;55:2376-83.
  26. Kim AL, Zhu Y, Zhu H, Han L, Kopelovich L, Bickers DR, Athar M. Resveratrol inhibits proliferation of human epidermoid carcinoma A431 cells by modulating MEK1 and AP-1 signalling pathways.2006;15:538-46.
  27. Ahmad N, Adhami VM, Afaq F, Feyes DK, Mukhtar H. Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells.2001;7:1466-73.
  28. Adhami VM, Afaq F, Ahmad N. Involvement of the retinoblastoma (pRb)-E2F/DP pathway during antiproliferative effects of resveratrol in human epidermoid carcinoma (A431) cells.2001;288:579-85.
  29. Niles RM, Cook CP, Meadows GG, Fu YM, McLaughlin JL, Rankin GO. Resveratrol is rapidly metabolized in athymic (nu/nu) mice and does not inhibit human melanoma xenograft tumor growth.2006;136:2542-6.
  30. Raschke WC, Baird S, Ralph P, Nakoinz I. Functional macrophage cell lines transformed by Abelson leukemia virus.1978;15:261-7.
  31. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H, Parks WP. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors.1973;51:1417-23.
  32. Foley GE, Lazarus H, Farber S, Uzman BG, Boone BA, McCarthy RE. Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia.1965;18:522-9.
  33. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.1983;65:55-63.
  34. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues.1969;27:502-22.
  35. Fraga CG, Leibovitz BE, Tappel AL. Lipid peroxidation measured as thiobarbituric acid-reactive substances in tissue slices: characterization and comparison with homogenates and microsomes.1988;4:155-61.
  36. Stervbo U, Vang O, Bonnesen C. Time- and concentration-dependent effects of resveratrol in HL-60 and HepG2 cells.2006;39:479-93.
  37. Surh YJ, Hurh YJ, Kang JY, Lee E, Kong G, Lee SJ. Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells.1999;140:1-10.
  38. Tsan MF, White JE, Maheshwari JG, Bremner TA, Sacco J. Resveratrol induces Fas signalling-independent apoptosis in THP-1 human monocytic leukaemia cells.2000;109:405-12.
  39. Velculescu VE, El Deiry WS. Biological and clinical importance of the p53 tumor suppressor gene.1996;42(6 Pt 1):858-68.
  40. Dong Z. Effects of food factors on signal transduction pathways.2000;12:17-28.
  41. Cimoli G, Malacarne D, Ponassi R, Valenti M, Alberti S, Parodi S. Meta-analysis of the role of p53 status in isogenic systems tested for sensitivity to cytotoxic antineoplastic drugs.2004;1705:103-20.
  42. Park DJ, Nakamura H, Chumakov AM, Said JW, Miller CW, Chen DL, Koeffler KP. Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines.1994;9:1899-906.
  43. Wong RP, Tsang WP, Chau PY, Co NN, Tsang TY, Kwok TT. p53-R273H gains new function in induction of drug resistance through down-regulation of procaspase-3.2007;6:1054-61.
  44. Schneider Y, Chabert P, Stutzmann J, Coelho D, Fougerousse A, Gosse F, Launary JF, Brouillard R, Raul F. Resveratrol analog (Z)-3,5,4'-trimethoxystilbene is a potent anti-mitotic drug inhibiting tubulin polymerization.2003;107:189-96.
  45. Chabert P, Fougerousse A, Brouillard R. Antimitotic properties of resveratrol analog (Z)-3,5,4'-trimethoxystilbene.2006;27:37-46.
  46. Mizutani K, Ikeda K, Kawai Y, Yamori Y. Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3-E1 cells.1998;253:859-63.
  47. van der Woude H, Gliszczynska-Swiglo A, Struijs K, Smeets A, Alink GM, Rietjens IM. Biphasic modulation of cell proliferation by quercetin at concentrations physiologically relevant in humans.2003;200:41-7.
  48. Elattar TM, Virji AS. The inhibitory effect of curcumin, genistein, quercetin and cisplatin on the growth of oral cancer cells in vitro.2000;20(3A):1733-8.
  49. Brito PM, Mariano A, Almeida LM, Dinis TC. Resveratrol affords protection against peroxynitrite-mediated endothelial cell death: A role for intracellular glutathione.2006;164:157-66.
  50. Cao Z, Li Y. Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes: protection against oxidative and electrophilic injury.2004;489:39-48.
  51. Surh YJ, Kundu JK, Na HK, Lee JS. Redox-sensitive transcription factors as prime targets for chemoprevention with anti-inflammatory and antioxidative phytochemicals.2005;135(12 Suppl):2993S-3001S.
  52. Hsieh TC, Lu X, Wang Z, Wu JM. Induction of quinone reductase NQO1 by resveratrol in human K562 cells involves the antioxidant response element ARE and is accompanied by nuclear translocation of transcription factor Nrf2.2006;2:275-85.
  53. Ahmad A, Syed FA, Singh S, Hadi SM. Prooxidant activity of resveratrol in the presence of copper ions: mutagenicity in plasmid DNA.2005;159:1-12.
  54. Azmi AS, Bhat SH, Hadi SM. Resveratrol-Cu(II) induced DNA breakage in human peripheral lymphocytes: implications for anticancer properties.2005;579:3131-5.
  55. Zheng LF, Wei QY, Cai YJ, Fang JG, Zhou B, Yang L, Liu ZL. DNA damage induced by resveratrol and its synthetic analogues in the presence of Cu (II) ions: mechanism and structure-activity relationship.2006;41:1807-16.
  56. Di Carlo FJ, Fiore JV. On the composition of zymosan.1958;127:756-7.
  57. Underhill DM. Macrophage recognition of zymosan particles.2003;9:176-80.
  58. Maeda H, Akaike T. Nitric oxide and oxygen radicals in infection, inflammation, and cancer.1998;63:854-65.
  59. Shvedova AA, Kisin ER, Mercer R, Murray AR, Johnson VJ, Potapovich AI, Tyurina YY, Gorelik O, Arepalli S, Schwegler-Berry D, Hubbs AF, Antonini J, Evans DE, Ku BK, Ramsey D, Maynard A, Kagan VE, Castranova V, Baron P. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice.2005;289(5):L698-L708.
  60. Kim BH, Lee IJ, Lee HY, Hwang BY, Han SB, Kim Y. Distinct inhibitory mechanisms of isoquercitrin gallate and its aglycone on zymosan-induced peroxynitrite production in macrophages. Nitric Oxide; in press (DOI: 10.1016/j.niox.2007.06.002).
  61. Speert DP, Wright SD, Silverstein SC, Mah B. Functional characterization of macrophage receptors for in vitro phagocytosis of unopsonized Pseudomonas aeruginosa.1988;82:872-9.
  62. Brown GD, Taylor PR, Reid DM, Willment JA, Williams DL, Martinez-Pomares L, Wong SY, Gordon S. Dectin-1 is a major beta-glucan receptor on macrophages.2002;196:407-12.
  63. Panzella L, De Lucia M, Amalfitano C, Pezzella A, Evidente A, Napolitano A, d'Ischia M. Acid-promoted reaction of the stilbene antioxidant resveratrol with nitrite ions: mild phenolic oxidation at the 4'-hydroxystiryl sector triggering nitration, dimerization, and aldehydeforming routes.2006;71:4246-54.
  64. De Lucia M, Panzella L, Crescenzi O, Napolitano A, Barone V, d'Ischia M. The catecholic antioxidant piceatannol is an effective nitrosation inhibitor via an unusual double bond nitration.2006;16:2238-42.
  65. Khan S, Ramwani JJ, O'Brien PJ. Hepatocyte toxicity of mechlorethamine and other alkylating anticancer drugs. Role of lipid peroxidation.1992;43:1963-7.
DOI: https://doi.org/10.2478/v10004-007-0020-8 | Journal eISSN: 1848-6312 (formerly 0004-1254) | Journal ISSN: 0004-1254
Language: English, Croatian
Page range: 293 - 304
Published on: Oct 3, 2007
Published by: Institute for Medical Research and Occupational Health
In partnership with: Paradigm Publishing Services

© 2007 Vijayalaxmi Radkar, Diane Hardej, Cesar Lau-Cam, Blase Billack, published by Institute for Medical Research and Occupational Health
This work is licensed under the Creative Commons License.